PFIZERPharmaceuticals
Pfizer Ltd — PE Ratio & Valuation Analysis
₹4720.50
-0.37%
Current P/E32.18xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E34.5x6.7% below avg
⚠️
1.3% Premium to Industry
PFIZER P/E 32.18x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹167.79 | ₹4988 | 29.7x |
| 2024 | ₹120.51 | ₹5282 | 43.8x |
| 2023 | ₹136.38 | ₹4269 | 31.3x |
| 2022 | ₹133.89 | ₹4432 | 33.1x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Pfizer Ltd Valuation
Pfizer Ltd (PFIZER) currently trades at 32.18x earnings. The Pharmaceuticals sector average PE is 31.77x. PFIZER commands a premium, reflecting high growth expectations. Historically, PFIZER has traded at an average PE of 34.5x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
16.40%
Dividend Yield
0.70%
More on Pfizer Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.